Organovo offers contract testing services utilizing ExVive™ 3D Bioprinted Human Liver Tissues. The tissues can be used in the evaluation of drug exposure for both acute (ex. 3-5 day) and chronic toxicity and metabolism studies. ExVive™ Human Liver Tissues remain fully functional and stable for greater than 28 days. Studies are comprised of both analytical and histological endpoints such as:
- Standard predictive toxicology endpoints (i.e., LDH, ATP, and Albumin)
- Gene/protein expression profiling
- Histological tissue assessment
Let us know how we can address toxicology testing needs for your preclinical drug discovery and development programs using our 3D human liver tissues.
Get more information on human liver tissue testing services »
Learn more about ExVive™ 3D Bioprinted Liver Tissues »
Figure 1: Analogous to human tissue biopsies, different patterns of damage can be detected histologically in ExVive™ 3D Bioprinted Liver Tissue using various treatments (H&E).
Figure 2: Hepatotoxic compound X and cytotoxin 20% DMSO show reproducible effects on ATP and LDH levels across hepatocyte donors in ExVive™ Human Liver Tissue.
Example Study Workflow
Consult with our scientists to design your 3D tissue studies for maximal impact